Bone marrow-derived mesenchymal stem cells for the treatment of limbus insufficiency
The purpose of the study is to determine whether transplantation of allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) is safe and effective in the treatment of limbus insufficiency syndrome, as compared to transplantation of allogeneic limbal stem cells.
Read More
No additional information regarding therapeutic cells was provided by the sponsor.
Read More
Product Information for
Bone marrow-derived mesenchymal stem cells for the treatment of limbus insufficiency